| Symbol: |
CDR2L
|
| Description: |
cerebellar degeneration-related protein 2-like [Source:HGNC Symbol;Acc:29999]
|
| Location: |
Chr17:72983727-73001895[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:277
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| CDR2L |
NSC 704430 |
0.005 |
Down |
| CDR2L |
NSC 704435 |
0.043 |
Down |
| CDR2L |
5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline-5,12(6H)-dione, 6-[3-[(2-hydroxyethyl)amino]propyl]-2,3-dimethoxy-, monohydrochloride |
0.026 |
Up |
| CDR2L |
NSC 707083 |
0.01 |
Down |
| CDR2L |
NSC 707778 |
0.035 |
Down |
| CDR2L |
NSC 708074 |
0.001 |
Up |
| CDR2L |
NSC 708075 |
0.002 |
Up |
| CDR2L |
NSC 708089 |
0.001 |
Up |
| CDR2L |
NSC 708446 |
0.046 |
Up |
| CDR2L |
NSC 708999 |
0.037 |
Up |
| CDR2L |
NSC 709079 |
0.008 |
Up |
| CDR2L |
Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- |
0.044 |
Up |
| CDR2L |
NSC 709482 |
0.005 |
Up |
| CDR2L |
NSC 709511 |
0.03 |
Up |
| CDR2L |
NSC 710333 |
0.023 |
Up |
Expression pattern: Sensitivity / Resistance
Total:19 Current:14
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:39
Total:3 Current:1
[First] [Prev]  Next Last 
|
| miRNA:
~ Export ~
|
Records:6
| Gene |
Gen_transcript |
miRNA |
miR_location |
| CDR2L |
ENST00000226235 |
hsa-mir-296-3p |
Chr20:57392681-57392702[-] |
| CDR2L |
ENST00000226235 |
hsa-mir-296-5p |
Chr20:57392716-57392736[-] |
| CDR2L |
ENST00000226235 |
hsa-mir-483-3p |
Chr11:2155372-2155392[-] |
| CDR2L |
ENST00000226235 |
hsa-mir-488-3p |
Chr1:176998510-176998530[-] |
| CDR2L |
ENST00000226235 |
hsa-mir-572 |
Chr4:11370511-11370530[+] |
| CDR2L |
ENST00000226235 |
hsa-mir-671-5p |
Chr7:150935535-150935557[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|